BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26572533)

  • 1. Diagnostic Clinical, Electrodiagnostic and Muscle Pathology Features of Spinal and Bulbar Muscular Atrophy.
    Jokela ME; Udd B
    J Mol Neurosci; 2016 Mar; 58(3):330-4. PubMed ID: 26572533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset Manifestations of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease).
    Finsterer J; Soraru G
    J Mol Neurosci; 2016 Mar; 58(3):321-9. PubMed ID: 26482145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
    Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
    Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.
    Querin G; Sorarù G; Pradat PF
    Rev Neurol (Paris); 2017 May; 173(5):326-337. PubMed ID: 28473226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.
    Breza M; Koutsis G
    J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Gozes I
    J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon.
    Alves CN; Braga TKK; Somensi DN; Nascimento BSVD; Lima JAS; Fujihara S
    Einstein (Sao Paulo); 2018 Jun; 16(2):eRC4011. PubMed ID: 29898093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New routes to therapy for spinal and bulbar muscular atrophy.
    Rocchi A; Pennuto M
    J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological changes of skeletal muscle in spinal and bulbar muscular atrophy (SBMA), Kennedy's disease: a case report.
    Acewicz A; Wierzba-Bobrowicz T; Lewandowska E; Sienkiewicz-Jarosz H; Sulek A; Antczak J; Rakowicz M; Ryglewicz D
    Clin Neuropathol; 2015; 34(4):199-206. PubMed ID: 25828775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of a genetically identified spinal and 
bulbar muscular atrophy pedigree].
    Wang Z; Chen Q; Li Q; Bi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1101-1105. PubMed ID: 27807335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
    Pennuto M; Rinaldi C
    Mol Cell Endocrinol; 2018 Apr; 465():113-121. PubMed ID: 28688959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Basso M
    J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal and bulbar muscular atrophy: pathogenesis and clinical management.
    Grunseich C; Rinaldi C; Fischbeck KH
    Oral Dis; 2014 Jan; 20(1):6-9. PubMed ID: 23656576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of spinal and bulbar muscular atrophy.
    Rhodes LE; Freeman BK; Auh S; Kokkinis AD; La Pean A; Chen C; Lehky TJ; Shrader JA; Levy EW; Harris-Love M; Di Prospero NA; Fischbeck KH
    Brain; 2009 Dec; 132(Pt 12):3242-51. PubMed ID: 19846582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kennedy's disease presented with mastication fatigue combined with positive titin antibody: a case report.
    Ji G; Huang R; Zhou X; Cao C; Wu Q; Li Z; Dong H; Song X; Liu Y
    BMC Neurol; 2022 Nov; 22(1):425. PubMed ID: 36376797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.
    Grunseich C; Zukosky K; Kats IR; Ghosh L; Harmison GG; Bott LC; Rinaldi C; Chen KL; Chen G; Boehm M; Fischbeck KH
    Neurobiol Dis; 2014 Oct; 70():12-20. PubMed ID: 24925468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.
    Pradat PF; Bernard E; Corcia P; Couratier P; Jublanc C; Querin G; Morélot Panzini C; Salachas F; Vial C; Wahbi K; Bede P; Desnuelle C;
    Orphanet J Rare Dis; 2020 Apr; 15(1):90. PubMed ID: 32276665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.
    Marchioretti C; Andreotti R; Zuccaro E; Lieberman AP; Basso M; Pennuto M
    Curr Opin Pharmacol; 2023 Aug; 71():102394. PubMed ID: 37463556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical symptoms of SBMA may not be androgen-dependent: implications from two SBMA mouse models.
    Xu Y; Halievski K; Katsuno M; Adachi H; Sobue G; Breedlove SM; Jordan CL
    Hum Mol Genet; 2018 Jul; 27(14):2425-2442. PubMed ID: 29897452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.
    Johansen JA; Yu Z; Mo K; Monks DA; Lieberman AP; Breedlove SM; Jordan CL
    Neurobiol Dis; 2009 Apr; 34(1):113-20. PubMed ID: 19211034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.